Starting in May, passengers traveling to Singapore will be able to use the IATA Travel Pass to share their pre-departure Covid-19 PCR test results at check-in and on arrival at the immigration checkpoints at Changi Airport as part of an ongoing collaboration between the Civil Aviation Authority of Singapore (CAAS) and IATA to facilitate seamless travel through the use of digital certificates of Covid-19 tests.
Following the successful trials by Singapore Airlines, the Singapore health and border control authorities will accept the IATA Travel Pass as a valid form of presentation of Covid-19 pre-departure test results for entry into Singapore. The information presented on the IATA Travel Pass will be in a format that satisfies Singapore’s prevailing Covid-19 pre-departure test requirements for entry into the country.
“Having the confidence of an aviation leader like Singapore accept IATA Travel Pass is hugely significant. Ongoing trials put us on track for IATA Travel Pass to be a critical tool for the industry’s restart by delivering verified travel health credentials to governments. And travelers can have complete confidence that their personal data is secure and under their own control. The success of our joint efforts will make IATA’s partnership with the government of Singapore a model for others to follow,” said Willie Walsh, IATA’s director general.
Kevin Shum, CAAS director general, added, “We have built upon our longstanding and deep partnership with IATA to develop solutions to facilitate travel. This latest collaboration with IATA demonstrates our shared commitment to drive the adoption of digital health certificates and restore international air travel. As we look to safely rebuild the Changi air hub, we will continue to explore other solutions that can provide similarly secure and verifiable means of sharing health certificates for safe international travel.”